Anavex Life Sciences
AVXL
AVXL
187 hedge funds and large institutions have $122M invested in Anavex Life Sciences in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.54% more ownership
Funds ownership: 42.22% → 42.76% (+0.54%)
10% less capital invested
Capital invested by funds: $136M → $122M (-$13.9M)
Holders
187
Holding in Top 10
–
Calls
$7.23M
Puts
$2.33M
Top Buyers
| 1 | +$6.9M | |
| 2 | +$2.85M | |
| 3 | +$2.63M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.41M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.93M |
Top Sellers
| 1 | -$4.37M | |
| 2 | -$1.38M | |
| 3 | -$1.32M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$1.26M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$990K |
